Home › Arrhythmia › NCT03604133
Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry
RecruitingObservational study
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC) Exclusion Criteria: * N/A
About the study
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Sponsor: QuesGen Systems Inc · Participants: 500 · Started: Aug 24, 2017
Contact the study team
- Michael Jarrett, MBA · Phone: 415-608-3570
- Martin Jorgensen, PhD · Phone: 650-777-7617
Official record on ClinicalTrials.gov — NCT03604133
Locations in the U.S.
| Utah | Cardio Surgical Partners, LLC, Lehi |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.